04786nam a22005655i 4500 978-3-031-54513-9 DE-He213 20251030112033.0 cr nn 008mamaa 240509s2024 sz | s |||| 0|eng d 9783031545139 978-3-031-54513-9 10.1007/978-3-031-54513-9 doi RL1-803 MJK bicssc MED017000 bisacsh MJK thema Management of Atopic Dermatitis [electronic resource] : Methods and Challenges / edited by Steven R. Feldman, Lindsay C. Strowd, Katie K. Lovell. 2nd ed. 2024. Cham : Springer International Publishing : Imprint: Springer, 2024. X, 248 p. 9 illus., 7 illus. in color. online resource. text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Advances in Experimental Medicine and Biology, 2214-8019 ; 1447 Introduction -- Atopic Dermatitis: Disease Background and Risk Factors -- Atopic Dermatitis: Pathophysiology -- Clinical Presentation of Atopic Dermatitis -- Special Considerations for Atopic Dermatitis in Skin of Color Patients -- Atopic Dermatitis Disease Complications -- The Psychosocial Impact of Atopic Dermatitis -- Stressors in Atopic Dermatitis -- The Economics Burden of Atopic Dermatitis -- Defining and Measuring the Scope of Atopic Dermatitis -- Topical Prescription Management (including new topical JAK) -- Oral Prescription Management (including new oral JAKs).-Introduction -- Atopic Dermatitis: Disease Background and Risk Factors -- Atopic Dermatitis: Pathophysiology -- Clinical Presentation of Atopic Dermatitis -- Special Considerations for Atopic Dermatitis in Skin of Color Patients -- Atopic Dermatitis Disease Complications -- The Psychosocial Impact of Atopic Dermatitis -- Stressors in Atopic Dermatitis -- The Economics Burden of Atopic Dermatitis -- Defining and Measuring the Scope of Atopic Dermatitis -- Topical Prescription Management (including new topical JAK) -- Oral Prescription Management (including new oral JAKs) -- Systemic Biologic Management (dupilumab and tralokinumab) -- Non-Prescription Treatment Options -- Adherence in Atopic Dermatitis -- Atopic Dermatitis: Managing the Itch -- Atopic Dermatitis Disease Education -- Guidelines from American Academy of Dermatology -- The Future of Atopic Dermatitis Treatment (to be updated—some drugs discussed in this chapter are now FDA approved). This new edition builds upon the foundational knowledge covered in the first edition, covering the epidemiology, pathogenesis, and clinical presentation of atopic dermatitis in both pediatric and adult patients. It provides an overview of the mechanism and presentation of atopic dermatitis and focuses on the management methods experienced dermatologists have used to successfully manage atopic dermatitis. The book includes new chapters describing the special considerations for atopic dermatitis in skin of color patients, dedicated chapters on topical and oral prescription management reflected the latest FDA-approved treatments, and also a chapter covering the updated guidelines from the American Academy of Dermatology. A final chapter includes updates on the future of atopic dermatitis treatment. This book provides physicians with insights into the management of atopic dermatitis, such as alternative treatments for pruritus, psychosocial impact on patients and families, assessing patient compliance, and patient resources. Dermatology. 72926 Epidemiology. 65983 Pathology. 74914 Dermatology. 72926 Epidemiology. 65983 Pathology. 74914 Feldman, Steven R. editor. edt http://id.loc.gov/vocabulary/relators/edt 64928 Strowd, Lindsay C. editor. edt http://id.loc.gov/vocabulary/relators/edt 76561 Lovell, Katie K. editor. edt http://id.loc.gov/vocabulary/relators/edt 76562 SpringerLink (Online service) Springer Nature eBook Printed edition: 9783031545122 Printed edition: 9783031545146 Printed edition: 9783031545153 Advances in Experimental Medicine and Biology, 2214-8019 ; 1447 67831 https://doi.org/10.1007/978-3-031-54513-9 ZDB-2-SBL ZDB-2-SXB 59732 59732